Characterization of cytokine gene expression associated with noninfectious human immunodeficiency virus retinopathy in human autopsy eyes

Retina

Volumn 30, Issue 6, 2010, Pages 952-957

  Kozak, Igor ^a   Cheng, Lingyun ^a   Rought, Steffney ^b,c   Woelk, Christopher ^b,c   Hardiman, Gary ^b,c   Barron, Erin C ^a   Schrier, Rachel D ^b,c   Corbeil, Jacques ^d   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN BCL 2; RANTES; MESSENGER RNA; PROTEIN BAX;

ARTICLE; AUTOPSY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PATHOGENESIS; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RETINOPATHY; RNA EXTRACTION; T LYMPHOCYTE ACTIVATION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RETINA DISEASE; VIRAL EYE INFECTION; VIROLOGY;

AUTOPSY; BCL-2-ASSOCIATED X PROTEIN; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CYTOKINES; EYE INFECTIONS, VIRAL; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DISEASES; RNA, MESSENGER;

EID: 77953338434     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181c700f8     Document Type: Article

References (33)

1. Kupperman BD, Petty JG, Richman DD, et al. The correlation between CD4+ counts and the prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115: 575-582.
2. Freeman WR, Chen A, Henderly DE, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989;107:229-235.
3. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology 1985;92:472-484.
4. Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIVassociatedretinopathyintheHAARTera. Retina 2005;25:633-649.
5. Kozak I, Bartsch DU, Cheng L, Freeman WR. In vivo histology of cotton-wool spots using high-resolution optical coherence tomography. Am J Ophthalmol 2006;141:748-750.
6. Kozak I, Bartsch DU, Cheng L, Freeman WR. Hyperreflective sign in resolved cotton wool spots using high resolution optical coherence tomography and OCTophthalmoscope. Ophthalmology 2007;114:537-543.
7. Plummer DJ, Bartsch DU, Azen SP, Max S, Sadun AA, Freeman WR. Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophthalmol 2001;131:216-222.
8. Kozak I, Bartsch DU, Cheng L, Kosobucki BR, Freeman WR. Objective analysis of retinal damage in HIV-positive patients in the HAARTera using OCT. AmJ Ophthalmol 2005;139: 295-301.
9. Kozak I, Bartsch DU, Cheng L, McCutchan A, Weinreb RN, Freeman WR. Scanning laser polarimetry demonstration of retinal nerve fiber layer damage in human immunodeficiency virus-positive patients without infectious retinitis. Retina 2007; 27:1267-1273.
10. Sample PA, Plummer DJ, Mueller AJ, et al. Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol 1999;117:755-760.
11. Shah KH, Holland GN, Yu F, et al. Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy. Am J Ophthalmol 2006;142:284-292.
12. Falkenstein I, Bartsch DU, Azen SP, Dustin L, Sadun AA, Freeman WR. Multifocal electroretinography in HIV positive patients without infectious retinitis. Am J Ophthalmol 2008; 146:570-588.
13. Kozak I, Sample PA, Hao J, et al. Machine learning classifiers detect subtle field defects in eyes of HIV individuals. Trans Am Ophthalmol Soc 2007;105:111-118.
14. Tufail A, Holland GN, Fisher TC, Cumberland WG, Meisel- man HJ. Increased polymorphonuclear leukocyte rigidity in HIV infected individuals. Br J Ophthalmol 2000;84:727-731.
15. Kim A, Dadgostar H, Holland GN, et al. Hemorheologic abnormalities associated with HIV infection: altered erythrocyte aggregation and deformability. Invest Ophthalmol Vis Sci 2006;47:3927-3932.
16. Yung CW, Harris A, Massicotte, et al. Retinal blood flow indices in patients infected with human immunodeficiency virus. Br J Ophthalmol 1996;80:723-727.
17. Lim MC, Cumberland WG, Minassian SL, et al. Decreased macular leukocyte velocity in human immunodeficiency virusinfected individuals. Am J Ophthalmol 2001;132:711-719.
18. Dadgostar H, Holland GN, Huang X, et al. Hemorheologic abnormalities associated with HIV infection: in vivo assessment of retinal microvascular blood flow. Invest Ophthalmol Vis Sci 2006;47:3933-3938.
19. Faber D,Wiley CA, Lynn GB, Gross JG, Freeman WR. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest Ophthalmol Vis Sci 1992;33:2345-2353.
20. Gonzalez CR, Wiley CA, Arevalo JF, et al. Polymerase chain reaction detection of cytomegalovirus and human immunodeficiency virus-1 in the retina of patients with acquired immune deficiency syndrome with and without cotton-wool spots. Retina 1996;16:305-311.
21. Rosenberg ZF, Fauci AS. The immunopathogenesis of HIV infection. Adv Immunol 1989;47:377-431.
22. Trumpfheller C, Tenner-Racz K, Racz P, Fleischer B, Frosch S. Expression of macrophage inflammatory protein MIP-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Clin Exp Immunol 1998;112:92-99.
23. Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA. Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest 1997;100:921-930.
24. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993;260: 355-358.
25. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol 2001;22:83-87.
26. Schmidtmayerova H, Nottet HS, Nuovo G, et al. Human immunodeficiency virus type 1 infection alters chemokine b peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A 1996;93:700-704.
27. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. Control of chemokine production at the blood-retina barrier. Immunology 2000;101:426-433.
28. Genini D, Sheeter D, Rought S, et al. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J 2001;15:5-6.
29. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-1197.
30. De Saint Jean M, Brignole F, Feldmann G, Goguel A, Baudouin C. Interferon-Y induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999;40:2199-2212.
31. Chavakis T, Cines DB, Rhee JS, et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J 2004; 18:1306-1308.
32. Scholtz M, Doerr HW, Cinatl J. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol 2003;11:171-178.
33. Kanagawa O, Vaupel BA, Gayama S, Koehler G, Kopf M. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993;262: 240-242.